| AL amyloidosis |
Systemic AL amyloidosis associated with multiple myeloma: real-world experience from a Tunisian hematology center
Rahal Amira, Tunisia
Video |
| CAR T cells / Transplantation |
Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Experience of the P.A. Herzen Moscow Oncology Research Institute (2020–2025)
Sergey Semochkin, Russia |
EVALUATING NUTRITIONAL INDICATORS AND TIME TO NEXT TREATMENT (TTNT) IN PATIENTS WITH MULTIPLE MYELOMA UNDERGOING STEM CELL TRANSPLANT: REAL WORLD DATA Background
Andrea Victoria Pacheco Sanchez, Mexico
Video |
Impact of Outpatient CAR T Cell Monitoring on Healthcare Utilization in Multiple Myeloma
Nadine Abdallah, USA |
REAL-WORLD EXPERIENCE WITH EARLY LINE CILTACABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
Brandon Kale, USA
Video |
TRIAL IN PROGRESS: QUINTESSENTIAL-2—A PHASE 3 STUDY OF ARLOCABTAGENE AUTOLEUCEL VERSUS STANDARD OF CARE IN ADULT PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM) EXPOSED TO LENALIDOMIDE
Eyal Lebel, Israel
Video |
| Immunotherapy |
A Case of Elranatamab Induced Primary Adrenal Insufficiency
Ebrar Uzunabdullah, Turkey |
REAL-WORLD SAFETY AND EARLY OUTCOMES OF TECLISTAMAB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SINGLE-CENTER EXPERIENCE FROM GUATEMALA
Pablo Jose Paredes Flores, Guatemala
Video |
WHAT COMES NEXT AFTER IMMUNE THERAPY IN MULTIPLE MYELOMA? REAL-WORLD SEQUENCING AFTER CAR-T AND BISPECIFIC ANTIBODIES
Jorge Arturo Hurtado Martinez, Canada
Video |
| Multiple myeloma |
A case report of relapsed multiple myeloma with concurrent infection of aspergillosis
Jiantuo Liu, China
Video |
A Rare Diagnostic Challenge: IgM Kappa Multiple Myeloma Mimicking Vertebral Metastasis After Prostate Cancer
Melis Bektaş, Turkey |
A SILENT MASS THAT SPEAKS FIRST: INTRACRANIAL PLASMACYTOMA AS THE INITIAL PRESENTATION OF MULTIPLE MYELOMA IN ELDERLY WOMAN
Ana Qose, Albania
Video |
Chronic myeloid leukemia with multiple myeloma in a single Tunisian patient
Fatma Turki, Tunisia |
COEXISTENCE OF MULTIPLE MYELOMA AND MYELOFIBROSIS: IS THERE A CORRELATION?
Rim Frikha, Tunisia |
COMPARISON OF SERUM-BASED METHODS AND BONE MARROW NEXT GENERATION FLOW CYTOMETRY FOR DISEASE MONITORING IN MULTIPLE MYELOMA: IS IT ALWAYS NECESSARY TO PERFORM BOTH?
Ana Catarina Fonseca, Portugal
Video |
Concurrent Essential Thrombocythemia and Multiple Myeloma Presenting With Marked Thrombocytosis at Diagnosis: A Rare Case Report
Gulsum Akgun Cagliyan, Turkey |
DEVELOPMENT OF AN STR PANEL FOR SCREENING OF 1P32.3 DELETION IN MULTIPLE MYELOMA
Natalya Risinskaya, Russia
Video |
DEVELOPMENT OF IN VITRO MODEL SYSTEM FOR FUNCTIONAL ASSESSMENT OF IMMUNOTHERAPY EFFICACY IN MULTIPLE MYELOMA
Dominika Balcerowska, Denmark
Video |
EXTERNAL VALIDATION OF A FIRTH-PENALIZED EASIX MORTALITY MODEL ACROSS FOUR INDEPENDENT LATIN AMERICAN AND ONE UNITED STATES HISPANIC-BASED COHORTS OF PATIENTS WITH MULTIPLE MYELOMA
Gledy Jimenez Tornero, Peru
Video |
EXTERNAL VALIDATION OF THE SAVED-VTE SCORE IN A CANADIAN REGIONAL CANCER CENTRE COHORT: A REAL-WORLD ANALYSIS
Raina Fatima, Canada
Video |
EXTRAMEDULLARY MULTIPLE MYELOMA: CLINICAL EXPERIENCE FROM A SINGLE CENTER
Yasmine Benjelloun, Morocco
Video |
GEOGRAPHIC PATTERNS IN HEALTHCARE BURDEN OF MULTIPLE MYELOMA IN SPAIN: TRENDS IN HOSPITALIZATION AND MORTALITY (2016–2023)
Ane Brieva López, Spain
Video |
IgD-λ Multiple Myeloma: A Case Report and Literature Review
Haiqin Zhang, China |
Infection Incidence, Timing, and Predictors in Newly Diagnosed Multiple Myeloma: A Real-World Retrospective Cohort Study
Ozlem Candan, Turkey
Video |
LAGOON (OP-115): A NON-INTERVENTIONAL STUDY OF MELPHALAN FLUFENAMIDE (MELFLUFEN) PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM) IN SPAIN ACCORDING TO THE APPROVED LABEL
Enrique M. Ocio, Spain
Video |
LENALIDOMIDE-INDUCED CUTANEOUS ADVERSE REACTIONS IN MULTIPLE MYELOMA: PREVALENCE IN REAL-WORLD CLINICAL PRACTICE
Yasmine Moutmir, France
Video |
Long-term progression-free survival benefit with ciltacabtagene autoleucel (cilta-cel) in standard-risk relapsed/refractory multiple myeloma (RRMM)
Salomon Manier, France |
MAINTAINED RENAL FUNCTION WITH MELFLUFEN THERAPY IN RRMM: RESULTS FROM ANALYSIS OF POOLED CLINICAL DATA
Paul G. Richardson, USA
Video |
MORTALITY OUTCOMES AND CLINICAL RISK FACTORS IN MULTIPLE MYELOMA
María Ordóñez García, Spain
Video |
MUCORMYCOSIS WITH CEREBRAL PARENCHYMAL INVOLVEMENT IN A PATIENT WITH A HISTORY OF AUTOLOGOUS STEM CELL TRANSPLANTATION AND RENAL TRANSPLANTATION
Handan Haydaroglu Sahin, Turkey |
National Evaluation of the 2016 Tunisian Protocol in Transplant-Eligible Multiple Myeloma: A Multicenter Real-World Study Informing the 2024 National Guidelines
Faten Kallel, Tunisia
Video |
NATIONAL TRENDS IN MULTIPLE MYELOMA RELATED HOSPITALIZATIONS IN SPAIN (2016–2023): INCREASING BURDEN AND REDUCED IN-HOSPITAL MORTALITY
Ane Brieva López, Spain
Video |
Novel Therapeutic Approaches in Relapsed/Refractory Multiple Myeloma Following Allogeneic Stem Cell Transplantation: A Case Report
Sebnem Izmir Guner, Turkey |
PERIPHERAL STEM CELL AUTOLOGOUS TRANSPLANTATION WITHOUT CRYOPRESERVATION: SINGLE-CENTER EXPERIENCE FROM THE HEMATOLOGY DEPARTMENT OF ORAN MILITARY HOSPITAL IN THE MANAGEMENT OF MULTIPLE MYELOMA
Soumeya Abderrahmani, Algeria
Video |
POMALIDOMIDE, CYCLOPHOSPHAMIDE, and DEXAMETHASONE in RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SINGLE-CENTER EXPERIENCE
Ayşe Uysal, Turkey |
PROGNOSTIC IMPACT OF BASELINE LABORATORY PARAMETERS ON MORTALITY IN PATIENTS WITH MULTIPLE MYELOMA: A RETROSPECTIVE COHORT STUDY
Abdukadir Karismaz, Turkey
Video |
Real-World Outcomes of Isatuximab-Carfilzomib-Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Single-Center Analysis Using the IMS/IMWG Consensus Genomic Staging
María Isabel Peris Feranud, Spain
Video |
Real-world outcomes of multiple myeloma in patients older than 65 years: a multicenter Tunisian study
Nesrine Ben Sayed, Tunisia
Video |
Real-World Practices of Primary Thromboprophylaxis in Multiple Myeloma: Insights from a Nationwide Survey of Moroccan Hematologists
Oumayma Hari, Morocco
Video |
RESPONSES INDUCED BY CYBORD IN MULTIPLE MYELOMA: OUTCOMES IN THE ABSENCE OF ASCT IN KOSOVA
Aferdita Ukimeraj, Kosovo
Video |
Subcutaneous daratumumab (Dara) + bortezomib/lenalidomide/dexamethasone (VRd) with Dara + lenalidomide (DR) maintenance in transplant-eligible (TE) patients (Pts) with newly diagnosed multiple myeloma (NDMM): analysis of sustained minimal residual disease negativity (MRD neg) in the phase 3 PERSEUS trial
Pieter Sonneveld, Netherlands |
THE REAL-WORLD INFLUENCE OF REGIMEN SELECTION ACROSS SUCCESSIVE LINES OF THERAPY IN MULTIPLE MYELOMA
Edgar Ricardo Olivas-Domínguez, Mexico
Video |
THROMBOTIC RISK STRATIFICATION IN MULTIPLE MYELOMA: PREDICTORS MISSING FROM IMPEDE-VTE SCORE IDENTIFIED IN MOROCCO
Siham Belkadi, Morocco
Video |
Truly Aggressive IgD Myeloma? Excellent Responses from Case Series
Siham Belkadi, Morocco
Video |
UNWANTED VARIATION IN POST-DOSE OBSERVATION FOR SUBCUTANEOUS DARATUMUMAB AND ITS IMPACT ON DAY-UNIT CAPACITY
Faye Sharpley, UK
Video |
Young Multiple Myeloma Patients (30–50 Years): The Depth of Response to First-Line Treatment Predicts Survival in a Single-Center Cohort Based on Real-World Data
Esra Pirinççi, Turkey
Video |
| NDMM |
IMMUNOPHENOTYPIC PROFILES AND ASSOCIATION WITH SURVIVAL AND CLINICAL STAGE IN NEWLY DIAGNOSED MULTIPLE MYELOMA: A RETROSPECTIVE STUDY IN RESOURCE-CONSTRAINED SETTINGS
Sri Agustini Kurniawati, Indonesia
Video |
ISATUXIMAB IN COMBINATION WITH BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (ISA-VRD) IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS NOT CANDIDATES FOR TRANSPLANTATION: CLINICAL PRACTICE EXPERIENCE IN FIVE HOSPITALS IN ANDALUSIA, SPAIN
Maria Esther Clavero Sanchez, Spain |
SPATIAL IMAGING UNLOCKS THE POTENTIAL OF CHARTING MULTIPLE MYELOMA AND EXTRAMEDULLARY DISEASE
Vanessa Desantis, Italy
Video |
| RRMM |
CHARACTERIZATION AND OUTCOMES OF SPANISH PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN THE MAJESTEC-1 AND REALITEC STUDIES
María Casanova, Spain
Video |
EFFICACY AND DURABILITY OF BELANTAMAB MAFODOTIN PLUS POMALIDOMIDE AND DEXAMETHASONE TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): LONG-TERM FOLLOW-UP OF THE PHASE 3 DREAMM-8 STUDY
Suzanne Trudel, Canada
Video |
Efficacy and Safety of Carfilzomib in Relapsed/Refractory Multiple Myeloma — Single-Center Experience (n=128)
S. Cherifa Guezlane, Algeria
Video |
INFECTION RATE PROFILE OF ETENTAMIG MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
Cesar Rodriguez Valdes, USA
Video |
KAPOSI SARCOMA DEVELOPMENT DURING THE COURSE OF ELRANATAMAB THERAPY: A CASE REPORT
Ayse Salihoglu, Turkey
Video |
Management of High-Risk Relapsed/Refractory Multiple Myeloma with Combination Chemo-Immunotherapy Leading to Allogeneic Stem Cell Transplantation
Sotirios Bristogiannis, Greece
Video |
Prevention Of Selinexor-Induced Nausea/Vomiting and Diarrhea in First Month of Therapy: A Novel Step-Up Dosing Approach
Tugba Zorlu, Turkey
Video |
Rare case of CNS myeloma, successfully treated with intrathecal chemotherapy, selinexor and craniospinal radiotherapy
Linas Davainis, Lithuania
Video |
REAL WORLD USE OF MELPHALAN FLUFENAMIDE (MELFLUFEN) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: PRELIMINARY RESULTS IN 60 PATIENTS FROM THE SPANISH REGISTRY
Adrián Alegre, Spain |
REAL-WORLD OUTCOMES OF GPRC5D- AND BCMA-TARGETING BISPECIFIC ANTIBODIES IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: ACTIVITY FOLLOWING PRIOR BCMA EXPOSURE
Dionisios Stoumbos, Greece |
| Smoldering myeloma / MGUS |
MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE PRESENTING AS MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS: REPORT OF TWO CASES
Soumeya Abderrahmani, Algeria
Video |
Patient Experiences and Perspectives on Early Intervention in Smoldering Multiple Myeloma: A Cross-Sectional Survey Study
Nadine Abdallah, USA |
RISK STRATIFICATION AND EARLY PROGRESSION PATTERNS IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: A 10-YEAR SINGLE-CENTER EXPERIENCE FROM TUNISIA
Nesrine Ben Sayed, Tunisia
Video |
| Other |
INFLUENCE OF ANEMIA ON COGNITIVE FUNCTIONS IN MYELOMA PATIENTS MEASURED BY COMPLEX RECTIONMETER DRENOVAC
Marija Stanić Damić, Croatia |
Plasma cell dyscrasias in HIV-infected patients: a single-center case series
Rahal Amira, Tunisia
Video |
